Skip to main content

Basil Michelle L's Form 4 filing

Haemonetics CorpHAE · filed May 29, 2024

Accession no.
0001127602-24-016810
Filed
May 29, 2024
Trade date
May 28-29, 2024
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions. Open-market sales total $1.14M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Basil Michelle LCIK 0001699629Officer (EVP and General Counsel)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 28, 2024Common StockAGrant or awardAcquired+24,748$0.00$056,005Direct
May 28, 2024Common StockFTax withholdingDisposed−11,758$95.73−$1,125,593.3444,247Direct
May 29, 2024Common StockSSaleDisposed−8,896$87.86F5−$781,602.5635,351Direct
May 29, 2024Common StockSSaleDisposed−4,094$88.57F6−$362,605.5831,257Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.28 to $88.28, inclusive. The reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (5) and (6) to this Form 4.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.29 to $88.92, inclusive.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)